• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因作为膀胱癌潜在生物标志物的评估。

Evaluation of Gene as a Potential Biomarker for Bladder Cancer.

机构信息

Medical Genetics Laboratory, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Selangor Darul Ehsan, Malaysia.

Perdana University School of Foundation Studies, Perdana University, Selangor Darul Ehsan, Malaysia.

出版信息

Dis Markers. 2019 Sep 15;2019:3875147. doi: 10.1155/2019/3875147. eCollection 2019.

DOI:10.1155/2019/3875147
PMID:31636736
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6766133/
Abstract

The ceramide synthase 2 () gene has been linked to tumour recurrence and invasion in many different types of cancers including bladder cancer. In this study, the expression levels of in bladder cancer cell lines were analysed using qRT-PCR and the protein expression in clinical bladder cancer histopathological specimens were examined via immunohistochemistry. The potential utility of as a predictive biomarker of response to oncolytic virotherapy was assessed by correlating the mRNA expression to IC values of cells treated with the Newcastle disease virus (NDV), AF2240 strain. This study demonstrates that is differentially expressed in different types of bladder cancer cell lines and that the siRNA-mediated downregulation of the expression of reduces the migratory potential of UMUC1 bladder cancer cells. However, there were no significant correlations between the expression levels of the CERS2 protein with bladder cancer grade/stage or between the IC50 values of cells treated with NDV and expression. Although the utility of expression may be limited, its potential as an antimigration cancer therapeutic should be further examined.

摘要

神经酰胺合酶 2 () 基因已与多种癌症(包括膀胱癌)的肿瘤复发和侵袭有关。在这项研究中,使用 qRT-PCR 分析膀胱癌细胞系中的表达水平,并通过免疫组织化学检查临床膀胱癌组织病理学标本中的蛋白表达。通过将 mRNA 表达与用新城疫病毒 (NDV)、AF2240 株处理的细胞的 IC 值相关联,评估了 作为溶瘤病毒治疗反应的预测生物标志物的潜在效用。本研究表明,在不同类型的膀胱癌细胞系中,表达水平不同,siRNA 介导的 表达下调降低了 UMUC1 膀胱癌细胞的迁移潜力。然而,CERS2 蛋白的表达水平与膀胱癌分级/分期之间或用 NDV 处理的细胞的 IC50 值与 表达之间没有显著相关性。尽管 的表达可能具有一定的局限性,但作为一种抗迁移癌症治疗的潜力应该进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bd5/6766133/45d46062d69d/DM2019-3875147.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bd5/6766133/ce3e5e7f11e3/DM2019-3875147.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bd5/6766133/755538ae4c57/DM2019-3875147.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bd5/6766133/ebc732265e54/DM2019-3875147.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bd5/6766133/3ce331563f8e/DM2019-3875147.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bd5/6766133/45d46062d69d/DM2019-3875147.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bd5/6766133/ce3e5e7f11e3/DM2019-3875147.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bd5/6766133/755538ae4c57/DM2019-3875147.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bd5/6766133/ebc732265e54/DM2019-3875147.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bd5/6766133/3ce331563f8e/DM2019-3875147.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bd5/6766133/45d46062d69d/DM2019-3875147.005.jpg

相似文献

1
Evaluation of Gene as a Potential Biomarker for Bladder Cancer.基因作为膀胱癌潜在生物标志物的评估。
Dis Markers. 2019 Sep 15;2019:3875147. doi: 10.1155/2019/3875147. eCollection 2019.
2
CERS2 suppresses tumor cell invasion and is associated with decreased V-ATPase and MMP-2/MMP-9 activities in breast cancer.CERS2抑制肿瘤细胞侵袭,且与乳腺癌中V-ATP酶以及MMP-2/MMP-9活性降低相关。
J Cell Biochem. 2015 Apr;116(4):502-13. doi: 10.1002/jcb.24978.
3
The Role of Longevity Assurance Homolog 2/Ceramide Synthase 2 in Bladder Cancer.长寿保证同源物 2/神经酰胺合酶 2 在膀胱癌中的作用。
Int J Mol Sci. 2023 Oct 27;24(21):15668. doi: 10.3390/ijms242115668.
4
Ceramide synthase 2-C -ceramide axis limits the metastatic potential of ovarian cancer cells.神经酰胺合酶 2-C-神经酰胺轴限制卵巢癌细胞的转移潜能。
FASEB J. 2021 Feb;35(2):e21287. doi: 10.1096/fj.202001504RR.
5
Expression profiles of proto-oncogene TWIST1 and tumor metastasis suppressor gene LASS2 in bladder cancer.原癌基因TWIST1和肿瘤转移抑制基因LASS2在膀胱癌中的表达谱
Cell Mol Biol (Noisy-le-grand). 2018 Aug 30;64(11):66-73.
6
Alternative splicing of ceramide synthase 2 alters levels of specific ceramides and modulates cancer cell proliferation and migration in Luminal B breast cancer subtype.丝氨酸棕榈酰转移酶 2 的可变剪接改变了特定神经酰胺的水平,并调节了 Luminal B 型乳腺癌亚型中癌细胞的增殖和迁移。
Cell Death Dis. 2021 Feb 10;12(2):171. doi: 10.1038/s41419-021-03436-x.
7
Disruption of ceramide synthesis by CerS2 down-regulation leads to autophagy and the unfolded protein response.通过下调神经酰胺合成酶2(CerS2)破坏神经酰胺合成会导致自噬和未折叠蛋白反应。
Biochem J. 2009 Nov 11;424(2):273-83. doi: 10.1042/BJ20090699.
8
Hsa-miR-3658 Promotes Cell Proliferation, Migration and Invasion by Effecting LASS2 in Bladder Cancer.人源微小RNA-3658通过影响LASS2促进膀胱癌细胞增殖、迁移和侵袭。
Clin Lab. 2018 Apr 1;64(4):515-525. doi: 10.7754/Clin.Lab.2017.171026.
9
Ceramide synthase 2 deletion decreases the infectivity of HIV-1.神经酰胺合酶2缺失降低了HIV-1的传染性。
J Biol Chem. 2021 Jan-Jun;296:100340. doi: 10.1016/j.jbc.2021.100340. Epub 2021 Jan 28.
10
Increased ceramide synthase 2 and 6 mRNA levels in breast cancer tissues and correlation with sphingosine kinase expression.乳腺癌组织中鞘氨醇合酶 2 和 6 mRNA 水平的升高与鞘氨醇激酶表达的相关性。
Biochem Biophys Res Commun. 2010 Jan 1;391(1):219-23. doi: 10.1016/j.bbrc.2009.11.035. Epub 2009 Nov 11.

引用本文的文献

1
The Drug Transporter P-Glycoprotein and Its Impact on Ceramide Metabolism-An Unconventional Ally in Cancer Treatment.药物转运蛋白 P-糖蛋白及其对神经酰胺代谢的影响——癌症治疗中的非传统盟友。
Int J Mol Sci. 2024 Sep 11;25(18):9825. doi: 10.3390/ijms25189825.
2
Proteomics Analysis of Interactions between Drug-Resistant and Drug-Sensitive Cancer Cells: Comparative Studies of Monoculture and Coculture Cell Systems.蛋白质组学分析耐药和敏感癌细胞之间的相互作用:单培养和共培养细胞系统的比较研究。
J Proteome Res. 2024 Jul 5;23(7):2608-2618. doi: 10.1021/acs.jproteome.4c00338. Epub 2024 Jun 22.
3
Identification of dysregulation of sphingolipids in retinoblastoma using liquid chromatography-mass spectrometry.

本文引用的文献

1
Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines.系统评价:膀胱癌细胞系的特征及临床前应用
Bladder Cancer. 2018 Apr 26;4(2):169-183. doi: 10.3233/BLC-180167.
2
Double agents: genes with both oncogenic and tumor-suppressor functions.双重角色基因:兼具致癌和抑癌功能的基因。
Oncogenesis. 2018 Mar 13;7(3):25. doi: 10.1038/s41389-018-0034-x.
3
Sphingolipid metabolism in cancer signalling and therapy.鞘脂代谢在癌症信号传导与治疗中的作用
采用液相色谱-质谱联用技术鉴定视网膜母细胞瘤中鞘脂的失调。
Exp Eye Res. 2024 Mar;240:109798. doi: 10.1016/j.exer.2024.109798. Epub 2024 Jan 19.
4
LASS2 enhances p53 protein stability and nuclear import to suppress liver cancer progression through interaction with MDM2/MDMX.LASS2通过与MDM2/MDMX相互作用增强p53蛋白稳定性和核输入,以抑制肝癌进展。
Cell Death Discov. 2023 Nov 14;9(1):414. doi: 10.1038/s41420-023-01709-2.
5
The Role of Longevity Assurance Homolog 2/Ceramide Synthase 2 in Bladder Cancer.长寿保证同源物 2/神经酰胺合酶 2 在膀胱癌中的作用。
Int J Mol Sci. 2023 Oct 27;24(21):15668. doi: 10.3390/ijms242115668.
6
Homeobox Gene Expression Dysregulation as Potential Diagnostic and Prognostic Biomarkers in Bladder Cancer.同源盒基因表达失调作为膀胱癌潜在的诊断和预后生物标志物
Diagnostics (Basel). 2023 Aug 10;13(16):2641. doi: 10.3390/diagnostics13162641.
7
Differential Protein Expression Patterns of HOXA13 and HOXB13 Are Associated with Bladder Cancer Progression.HOXA13和HOXB13的差异蛋白表达模式与膀胱癌进展相关。
Diagnostics (Basel). 2023 Aug 9;13(16):2636. doi: 10.3390/diagnostics13162636.
8
Role of ceramides in diabetic foot ulcers (Review).神经酰胺在糖尿病足溃疡中的作用(综述)。
Int J Mol Med. 2023 Mar;51(3). doi: 10.3892/ijmm.2023.5229. Epub 2023 Feb 17.
9
Development of prognostic signature based on immune-related genes in muscle-invasive bladder cancer: bioinformatics analysis of TCGA database.基于免疫相关基因的肌层浸润性膀胱癌预后标志物的构建:TCGA 数据库的生物信息学分析。
Aging (Albany NY). 2021 Jan 19;13(2):1859-1871. doi: 10.18632/aging.103787.
Nat Rev Cancer. 2018 Jan;18(1):33-50. doi: 10.1038/nrc.2017.96. Epub 2017 Nov 17.
4
LASS2 inhibits growth and invasion of bladder cancer by regulating ATPase activity.LASS2通过调节ATP酶活性抑制膀胱癌的生长和侵袭。
Oncol Lett. 2017 Feb;13(2):661-668. doi: 10.3892/ol.2016.5514. Epub 2016 Dec 20.
5
Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression.细胞外囊泡作为膀胱癌进展中非侵入性生物标志物的来源。
Eur J Pharm Sci. 2017 Feb 15;98:70-79. doi: 10.1016/j.ejps.2016.10.008. Epub 2016 Oct 15.
6
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends.膀胱癌发病率和死亡率:全球概述及最新趋势。
Eur Urol. 2017 Jan;71(1):96-108. doi: 10.1016/j.eururo.2016.06.010. Epub 2016 Jun 28.
7
Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response.用于模拟肿瘤生物学和药物反应的尿路上皮癌细胞系的分子分析。
Oncogene. 2017 Jan 5;36(1):35-46. doi: 10.1038/onc.2016.172. Epub 2016 Jun 6.
8
Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency.副粘病毒的溶瘤作用:多种机制有助于提高治疗效果。
Mol Ther Oncolytics. 2015;2:15011-. doi: 10.1038/mto.2015.11. Epub 2015 Jul 22.
9
Oncolysis by paramyxoviruses: preclinical and clinical studies.副粘病毒介导的肿瘤溶解:临床前和临床研究
Mol Ther Oncolytics. 2015;2:15017-. doi: 10.1038/mto.2015.17. Epub 2015 Oct 21.
10
Biomarkers for non-muscle invasive bladder cancer: Current tests and future promise.非肌肉浸润性膀胱癌的生物标志物:当前检测方法与未来前景
Indian J Urol. 2015 Oct-Dec;31(4):273-82. doi: 10.4103/0970-1591.166448.